Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Humoral and cellular immunity to primary H1N1 infection in patients with hematologic malignancies following stem cell transplantation.

Garland P, de Lavallade H, Sekine T, Hoschler K, Sriskandan S, Patel P, Brett S, Stringaris K, Loucaides E, Howe K, Marin D, Kanfer E, Cooper N, Macdonald D, Rahemtulla A, Atkins M, Danga A, Milojkovic D, Gabriel I, Khoder A, Alsuliman A, Apperley J, Rezvani K.

Biol Blood Marrow Transplant. 2011 May;17(5):632-9. doi: 10.1016/j.bbmt.2010.08.002. Epub 2010 Aug 11.

PMID:
20708085
[PubMed - indexed for MEDLINE]
2.

Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host.

de Lavallade H, Garland P, Sekine T, Hoschler K, Marin D, Stringaris K, Loucaides E, Howe K, Szydlo R, Kanfer E, Macdonald D, Kelleher P, Cooper N, Khoder A, Gabriel IH, Milojkovic D, Pavlu J, Goldman JM, Apperley JF, Rezvani K.

Haematologica. 2011 Feb;96(2):307-14. doi: 10.3324/haematol.2010.032664. Epub 2010 Oct 22.

PMID:
20971824
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Long-term patterns of humoral and cellular response after vaccination against influenza A (H1N1) in patients with hematologic malignancies.

Mariotti J, Spina F, Carniti C, Anselmi G, Lucini D, Vendramin A, Pregliasco F, Corradini P.

Eur J Haematol. 2012 Aug;89(2):111-9. doi: 10.1111/j.1600-0609.2012.01793.x. Epub 2012 May 31.

PMID:
22540245
[PubMed - indexed for MEDLINE]
4.

Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination.

Wagar LE, Rosella L, Crowcroft N, Lowcock B, Drohomyrecky PC, Foisy J, Gubbay J, Rebbapragada A, Winter AL, Achonu C, Ward BJ, Watts TH.

PLoS One. 2011;6(11):e28063. doi: 10.1371/journal.pone.0028063. Epub 2011 Nov 23.

PMID:
22132212
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.

Roll D, Ammer J, Holler B, Salzberger B, Schweiger B, Jilg W, Andreesen R, Edinger M, Wolff D, Holler E.

Infection. 2012 Apr;40(2):153-61. doi: 10.1007/s15010-011-0206-5. Epub 2011 Oct 29.

PMID:
22038110
[PubMed - indexed for MEDLINE]
7.

Pandemic influenza vaccination elicits influenza-specific CD4+ Th1-cell responses in hypogammaglobulinaemic patients: four case reports.

Pedersen G, Halstensen A, Sjursen H, Naess A, Kristoffersen EK, Cox RJ.

Scand J Immunol. 2011 Aug;74(2):210-8. doi: 10.1111/j.1365-3083.2011.02561.x.

PMID:
21438900
[PubMed - indexed for MEDLINE]
8.

Long term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipients.

Baluch A, Humar A, Egli A, Gubbay J, Lisboa L, Wilson L, Kumar D.

PLoS One. 2011;6(12):e28627. doi: 10.1371/journal.pone.0028627. Epub 2011 Dec 14.

PMID:
22194870
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Cellular and humoral immunity elicited by influenza vaccines in pediatric hematopoietic-stem cell transplantation.

Guérin-El Khourouj V, Duchamp M, Krivine A, Pédron B, Ouachée-Chardin M, Yakouben K, Frémond ML, Baruchel A, Dalle JH, Sterkers G.

Hum Immunol. 2012 Sep;73(9):884-90. doi: 10.1016/j.humimm.2012.07.039. Epub 2012 Jul 20.

PMID:
22820626
[PubMed - indexed for MEDLINE]
10.

Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation.

Avetisyan G, Aschan J, Hassan M, Ljungman P.

Transplantation. 2008 Jul 27;86(2):257-63. doi: 10.1097/TP.0b013e3181772a75.

PMID:
18645488
[PubMed - indexed for MEDLINE]
11.

Innovative two-step negative selection of granulocyte colony-stimulating factor-mobilized circulating progenitor cells: adequacy for autologous and allogeneic transplantation.

Rambaldi A, Borleri G, Dotti G, Bellavita P, Amaru R, Biondi A, Barbui T.

Blood. 1998 Mar 15;91(6):2189-96.

PMID:
9490708
[PubMed - indexed for MEDLINE]
Free Article
12.

The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic.

Engelhard D, Zakay-Rones Z, Shapira MY, Resnick I, Averbuch D, Grisariu S, Dray L, Djian E, Strauss-Liviatan N, Grotto I, Wolf DG, Or R.

Vaccine. 2011 Feb 17;29(9):1777-82. doi: 10.1016/j.vaccine.2010.12.113. Epub 2011 Jan 7.

PMID:
21216315
[PubMed - indexed for MEDLINE]
13.

Cell-mediated immune responses to influenza vaccination in healthy volunteers and allogeneic stem cell transplant recipients.

Avetisyan G, Ragnavölgyi E, Toth GT, Hassan M, Ljungman P.

Bone Marrow Transplant. 2005 Sep;36(5):411-5.

PMID:
15980884
[PubMed - indexed for MEDLINE]
14.

Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?

Allwinn R, Geiler J, Berger A, Cinatl J, Doerr HW.

Med Microbiol Immunol. 2010 May;199(2):117-21. doi: 10.1007/s00430-010-0143-4. Epub 2010 Feb 17.

PMID:
20162304
[PubMed - indexed for MEDLINE]
15.

Differential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients.

Rambal V, Müller K, Dang-Heine C, Sattler A, Dziubianau M, Weist B, Luu SH, Stoyanova A, Nickel P, Thiel A, Neumann A, Schweiger B, Reinke P, Babel N.

Med Microbiol Immunol. 2014 Feb;203(1):35-45. doi: 10.1007/s00430-013-0312-3. Epub 2013 Sep 22.

PMID:
24057515
[PubMed - indexed for MEDLINE]
16.

Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.

Guihot A, Luyt CE, Parrot A, Rousset D, Cavaillon JM, Boutolleau D, Fitting C, Pajanirassa P, Mallet A, Fartoukh M, Agut H, Musset L, Zoorob R, Kirilovksy A, Combadière B, van der Werf S, Autran B, Carcelain G; FluBAL Study Group.

Am J Respir Crit Care Med. 2014 May 15;189(10):1240-9. doi: 10.1164/rccm.201311-2071OC.

PMID:
24646009
[PubMed - indexed for MEDLINE]
17.

Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.

Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.

Arthritis Rheum. 2009 Aug;60(8):2438-47. doi: 10.1002/art.24679.

PMID:
19644961
[PubMed - indexed for MEDLINE]
Free Article
18.

Pandemic 2009 H1N1 influenza in patients with hematopoietic stem cell transplantation and hematologic malignancy: single center experience.

Tekgündüz E, Yüksel MK, Erbay C, Arıbaş B, Özdilekcan C, Arslan H, Koçubaba S, Demiriz I, Tetik A, Arda K, Altuntaş F.

Oncology. 2010;79(5-6):409-14. doi: 10.1159/000320789. Epub 2011 Mar 31.

PMID:
21455013
[PubMed - indexed for MEDLINE]
19.

ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients.

Lindemann M, Witzke O, Lütkes P, Fiedler M, Kreuzfelder E, Philipp T, Roggendorf M, Grosse-Wilde H.

Clin Immunol. 2006 Sep;120(3):342-8. Epub 2006 Apr 21.

PMID:
16631409
[PubMed - indexed for MEDLINE]
20.

Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.

Lilleri D, Fornara C, Chiesa A, Caldera D, Alessandrino EP, Gerna G.

Haematologica. 2008 Feb;93(2):248-56. doi: 10.3324/haematol.11912.

PMID:
18245650
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk